Entamoeba histolytica and Probable Effect on Production Microsatellite Instability in Colorectal Cancer

• Published in: Current microbiology 2022-04, Vol.79 (4), p.111-111, Article 111
• Main Authors: Haghighi, Leila, Razmjou, Elham, Rafiei-Sefiddashti, Raheleh, Meamar, Ahmad Reza, Akhlaghi, Lame
• Format: Article
• Language: English
• Subjects: Adenocarcinoma; Biomedical and Life Sciences; Biopsy; Biotechnology; Biotic factors; Cancer; Colitis; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - genetics; Dysplasia; Entamoeba histolytica; Entamoeba histolytica - genetics; Environmental factors; Humans; Hyperplasia; Inflammatory bowel disease; Life Sciences; Microbiology; Microsatellite Instability; Microsatellite Repeats; Paraffin; Paraffins; Parasites; Pathogens; Polymerase Chain Reaction; Polyps; Tumors
• ISSN: 0343-8651; 1432-0991
• DOI: 10.1007/s00284-022-02782-z

The mortality rate of Entamoeba histolytica is still high and approximately 100,000 per year. Environmental factors and different pathogens can cause microsatellite instability (MSI) positive, which may be one reason for colorectal cancer. MSI status can play an essential role in treatment. Moreover, E. histolytica might be one of the pathogens which raise the incidence of colorectal cancer. Therefore, the probable relationship of E. histolytica with MSI production was evaluated. Four hundred samples of colorectal biopsies based on pathological reports were divided into four groups: colitis, polyps, hyperplasia or dysplasia, and adenocarcinoma. The prevalence of E. histolytica was examined with PCR and immunohistochemical staining (IHC) for the light chain lectin HK-9. The adenocarcinoma formalin-fixed paraffin-embedded colorectal tumours sections were tested for MSI genes. We detected  E. histolytica in 6% and 4% of colitis samples by PCR and IHC technique, respectively. However, it did not identify in polyp and hyperplasia samples. The MSI test was examined in the colorectal cancer group, which became positive in 19%. Entamoeba histolytica was detected in 26.3% (5/19) of MSI-positive and 2.5% (2/81) of MSI-negative cases by IHC technique however was not identified by PCR assay in this group. It is concluded PCR and IHC assay is recommended as complementary tests in colitis biopsies. Simultaneous PCR and IHC negative results could confirm the non-existence of the parasite with more confidence. Consequently, E. histolytica might be one of the biotic  factors which raise the incidence of colorectal cancer because of the coincidence of the IHC positive results in MSI-positive adenocarcinoma.